Chemokines in Vitiligo Pathogenesis: CXCL10 and 12

Area of Science:

• Immunodermatology
• Autoimmune diseases
• Chemokine signaling

Background:

• Vitiligo affects 0.5-1% of the global population, causing skin depigmentation and psychological distress.
• Chemokines C-X-C motif chemokine ligand 9 (CXCL9), CXCL10, CXCL11, and CXCL12 are implicated in Th1-mediated autoimmune responses.
• These chemokines may drive T-cell mediated melanocyte destruction in vitiligo.

Purpose of the Study:

• To investigate the role of CXCL10 and CXCL12 in vitiligo pathogenesis.
• To determine the relationship between CXCL10 and CXCL12 levels and vitiligo disease activity.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to measure serum CXCL10 and CXCL12 levels.
• Study included 40 non-segmental vitiligo (NSV) patients (20 active, 20 stable) and 20 healthy controls.
• Patients and controls were age- and sex-matched.

Main Results:

• Serum CXCL10 levels were significantly higher in vitiligo patients compared to controls.
• A statistically significant difference in serum CXCL10 levels was observed between active and stable vitiligo patients, with higher levels in active cases.
• Serum CXCL12 levels were also noted to be increased in vitiligo patients.

Conclusions:

• Increased serum levels of CXCL10 and CXCL12 are associated with vitiligo.
• CXCL10 and CXCL12 show a positive correlation with disease activity in vitiligo.
• These findings suggest a significant role for CXCL10 and CXCL12 in the pathogenesis of vitiligo.